Question 1

What Is Pinealon? Tripeptide Research Overview

Accepted Answer

Pinealon is a synthetic tripeptide composed of three amino acids: glutamic acid, aspartic acid, and arginine (Glu-Asp-Arg or EDA). It was developed by the research group of Vladimir Khavinson at the Saint Petersburg Institute of Bioregulation and Gerontology, where it was investigated as part of a broader research program examining short peptide bioregulators derived from tissue fractions. Available at Spartan Peptides for in vitro laboratory research only.

Question 2

Research Background and Origins

Accepted Answer

The Khavinson group has published several dozen papers on short peptide bioregulators since the 1980s. Their research program began with peptide fractions extracted from animal gland tissue, then moved to synthetic equivalents once active sequences were characterized. Pinealon corresponds to the peptide fraction associated with pineal gland tissue in that original extraction research. The rationale, as described in Khavinson's published work, is that short peptides from specific tissues may carry sequence information relevant to gene expression regulation in those tissues. Published papers from the group have appeared in journals including Bulletin of Experimental Biology and Medicine and Advances in Gerontology.

Question 3

Preclinical Research Models Examined

Accepted Answer

Published studies have examined pinealon in rodent models focused on neurological parameters including oxidative stress markers, mitochondrial function assays, and behavioral endpoints in aging cohorts. The compound has also appeared in cell-based studies examining its interactions with DNA and gene expression regulatory elements, which the Khavinson group proposed as a mechanism for its activity. It's worth noting that most published pinealon research comes from a single research group. Independent replication in Western institutions is limited, which researchers should factor into their assessment of the existing literature when designing their own studies.

Question 4

Mechanism: What Research Has Proposed

Accepted Answer

Khavinson's group proposed that pinealon (and other short peptides in their catalog) exerts biological effects partly through direct interaction with double-stranded DNA, influencing promoter regions of genes related to antioxidant defense and cell survival pathways. This proposed mechanism is distinct from classical receptor-mediated signaling and remains an area of active investigation. The molecular weight of pinealon (approximately 418 Da) is low enough to potentially enter cells and nuclei, a property that complicates standard receptor binding interpretations.

Question 5

Research Availability

Accepted Answer

Spartan Peptides supplies pinealon as a lyophilized research peptide with HPLC and mass spectrometry documentation. Each lot is accompanied by a certificate of analysis from an independent analytical lab. The compound is available for in vitro laboratory use only and is not represented as a therapeutic or clinical product.

GLP-3(Reta) | Triple-Agonist Metabolic Research

NAD+ 750mg | Cellular Energy & DNA Repair Research

MOTS-c | Mitochondrial Metabolism Research Peptide

BPC-157 5mg | Tissue Repair & Gut Health Research

What Is Pinealon? Frequently Asked Questions

Explore Full Research Index